Identification of Ovarian Cancer Patients Most Likely to Achieve Chemotherapy Response Score 3 Following Neoadjuvant Chemotherapy: Development of a Predictive Nomogram

Background: The chemotherapy response score (CRS) system is a reproducible prognostic tool for patients receiving neoadjuvant chemotherapy (NACT) for tubo-ovarian high-grade serous carcinoma (HGSC). Achieving CRS 3 following NACT can be used as a surrogate for progression-free survival (PFS) and ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Wei-feng, Li, Hui, Wu, Jie-ying, Liu, Chang-hao, Wu, Miao-fang, Li, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571668/
https://www.ncbi.nlm.nih.gov/pubmed/33123471
http://dx.doi.org/10.3389/fonc.2020.560888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571668/
https://www.ncbi.nlm.nih.gov/pubmed/33123471
http://dx.doi.org/10.3389/fonc.2020.560888

Ejemplares similares